C12N 2770/32043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2770/32043 (Viral genome or elements thereof as genetic vector) appears on 3 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 20
- Assignees
- 22
- Inventors
- 85
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 4 |
| 2025 | 1 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical composition containing stabilized nucleic acid adjuvant11 Nov 2025US 12,465,644 B2Sml Biopharm Co., Ltd.
- Enhanced expression of RNA vectors27 Dec 2022US 11,534,417 B2The University Court of the University of Edinburgh
- Gene-modified coxsackievirus18 Sep 2018US 10,076,547 B2Kyushu University, National University Corporation
- Artificial secoviridae satellite rnas1 Oct 2026US 2026/0297596 A1Flagship Pioneering Innovations Vii, LLC
- Production of rna polynucleotides encoding picornavirus11 Sep 2025US 2025/0281556 A1ElevateBio Technologies, Inc.
- Replicon Compositions and Methods of Using Same for the Treatment of Diseases11 Sep 2025US 2025/0281602 A1BioNTech SE
- Coxsackievirus b4 strain and application thereof9 Jan 2025US 2025/0009867 A1Institute of Medical Biology, Chinese Academy of Medical Sciences
- Compounds, compositions, and methods of using thereof7 Nov 2024US 2024/0366518 A1ElevateBio Technologies, Inc.
Most cited
By later US patents